This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar;13(3):217-8.

doi: 10.1016/S1470-2045(12)70082-7. Epub 2012 Feb 16.

Maintenance chemotherapy in advanced non-small-cell lung cancer

Affiliations

PMID: 22341743
DOI: 10.1016/S1470-2045(12)70082-7

Comment

Maintenance chemotherapy in advanced non-small-cell lung cancer

Jacek Jassem. Lancet Oncol. 2012 Mar.

. 2012 Mar;13(3):217-8.

doi: 10.1016/S1470-2045(12)70082-7. Epub 2012 Feb 16.

Author

Affiliation

¹ Department of Oncology and Radiotherapy, Medical University of Gdańsk, 80-211 Gdańsk, Poland. jjassem@gumed.edu.pl

PMID: 22341743
DOI: 10.1016/S1470-2045(12)70082-7

No abstract available

PubMed Disclaimer

Comment on

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C. Paz-Ares L, et al. Lancet Oncol. 2012 Mar;13(3):247-55. doi: 10.1016/S1470-2045(12)70063-3. Epub 2012 Feb 16. Lancet Oncol. 2012. PMID: 22341744 Clinical Trial.

Similar articles

Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer.
Wang Y, Yang J, Lu YJ. Wang Y, et al. Lung. 2015 Dec;193(6):1057. doi: 10.1007/s00408-015-9816-5. Epub 2015 Oct 6. Lung. 2015. PMID: 26440277 No abstract available.
[Chemotherapy for advanced non-small-cell lung cancer: combinations without platinium derivatives].
Pujol JL. Pujol JL. Rev Pneumol Clin. 2004 Nov;60(5 Pt 3):4S17-4S19. Rev Pneumol Clin. 2004. PMID: 15687988 Review. French. No abstract available.
Cytotoxic chemotherapy in advanced non-small cell lung cancer.
Scagliotti GV, Novello S, Selvaggi G. Scagliotti GV, et al. Monaldi Arch Chest Dis. 2005 Dec;63(4):181-3. doi: 10.4081/monaldi.2005.618. Monaldi Arch Chest Dis. 2005. PMID: 16454216 No abstract available.
Chemotherapy for advanced lung cancer.
Blackhall F, Thatcher N. Blackhall F, et al. Eur J Cancer. 2004 Nov;40(16):2345-8. doi: 10.1016/j.ejca.2004.06.026. Eur J Cancer. 2004. PMID: 15519503 No abstract available.
[Chemotherapy in the treatment of advanced metastatic non-small cell carcinoma of the lung].
Cortesi E, Nelli F. Cortesi E, et al. Suppl Tumori. 2004 Mar-Apr;3(2):S52-5. Suppl Tumori. 2004. PMID: 15067969 Review. Italian. No abstract available.

See all similar articles

Cited by

Vandetanib in advanced non small cell lung cancer: a promise unfulfilled.
de Boer RH. de Boer RH. Transl Lung Cancer Res. 2013 Feb;2(1):E7-9. doi: 10.3978/j.issn.2218-6751.2012.11.03. Transl Lung Cancer Res. 2013. PMID: 25806216 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information